Introduction
Andrographolide (AD) is a labdane diterpenoid, obtained from the herb Andrographis paniculata and is responsible for most of its pharmacological properties including anti-cancer activity 1 . The compound is able to induce a G0/G1 cell-cycle arrest in various kinds of cancer cell, activates the death receptor pathways, induces TRAIL (TNF-related apoptosis-inducing ligand)-mediated apoptosis and causes inhibition of NF-11B transcriptional factors and various angiogenic factors 2 . But the effectiveness of the drug was hampered by its low aqueous solubility (3.29 ± 0.73 mg/ml), high lipophilicity having log p value ¼ 2.632 ± 0.135 and low bioavailability 3 . Nano-formulations are attractive for their potential to improve biopharmaceutic properties of herbal drugs 4 . Solid lipid nanoparticles (SLNs) are colloidal carriers made up of lipids that remain solid at room temperature and body temperature and also offer unique properties such as small size (50-500 nm), favorable zeta potential (i.e. responsible for its stability properties), smooth and spherical shape and less toxic than polymeric nanoparticulate systems as the lipid matrix is made from physiologically tolerated lipid components, which decreases the potential for acute and *These authors have equal contribution.
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7 . The present study elucidates an attempt to design and characterize a SLN formulation of AD (AD-SLNs), along with the in vitro and pharmacokinetic studies, to improve the oral bioavailability. The antitumor activity was also carried out on Balb/c mice treated with Ehrlich's ascites carcinoma (EAC) cells.
Materials and methods

Materials
AD (98%) was procured from ChromaDex (Irvine, CA) and Compritol ATO 888 (glycerol dibehenate), Dynasan 116 (glyceryl tristearate), Dynasan 114 (glyceryl trimyristate), Precirol ATO 5 (glycerol distearate) from Gattefosse (St Priest, France) as a gift samples. Glyceryl monostearate, stearic acid and Tween 80 (polyoxyethylene sorbitan mono oleate) were purchased from S.D. Fine Chemicals (Mumbai, India). Water was taken from Milli-Q water purification system (Millipore, Billerica, MA). All other chemicals and reagents used were of analytical (AR) grade and procured from Merck (Mumbai, India) and S.D. Fine Chemicals (Mumbai, India). All the components used for the formulation of nanoparticles were pharmaceutically acceptable for oral administration. The MS grade solvents (acetonitrile, methanol, formic acid) used in UPLC-MS method were procured from Sigma Aldrich (St. Louis, MO).
Dulbecco's modified Eagle's medium (DMEM), 3-(4,5-dimethylthiazole-2-yl)-2, 5-diphenyl tetrazolium bromide (MTT)
Introduction
Andrographolide (Fig. 1A) , a labdane diterpenoid, is the prime constituent extracted from the leaves of Andrographis paniculata (Burm.f.) Nees. (Acanthaceae) and is responsible for most of its pharmacological properties including anti-cancer activity [1] . Betulinic acid (Fig. 1B) , a pentacyclic lupanetype triterpene, is obtained mainly from the outer bark of Betula alba [2] of the family Betulaceae. Both the drugs are reported against several types of human cancers, including neuroblastoma, glioblastoma, medulloblastoma, as well as several carcinomas, i.e., colon, breast, hepatocellular, lung, prostate, and cervix carcinoma [1, 2].
I. INTRODUCTION
Despite the concerted efforts put in by various researchers in designing the different therapeutic modalities, the success rate of certain cancer treatment regimens is only partial, with limited effect on long-term prognosis. Therefore, the scientists have been trying to work out not only new methods but to put the already available ones in combinations that would cure as well as prevent the recurrence of the disease. Conventionally, the whole knapsack of cancer treatments can be redistributed into three packets, namely, surgery, chemotherapeutics, and mechanophysical killing of cancer cells. Different permutations and combinations of the material of these three packets have been tried to achieve the desired response in a patient. The combination is designed with the view that synergistic response of the participants kills the maximum number of cells as well as prevents the recurrence of the problem. 0743-4863/12/$35.00 ©2012 Begell House, Inc. www.begellhouse.com 
